HEATHER RAHIM: Open Payments
NPI 1679977284 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 23 payments from 14 companies in 2025. Trend: 2023 $200 · 2024 $972 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $160 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Alexion Pharmaceuticals, Inc. | 1 | $31 |
| Novo Nordisk Inc | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Ardelyx, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $26 |
| Fresenius USA Marketing, Inc. | 1 | $25 |
Products named: Vanrafia, BENLYSTA, LOKELMA, JARDIANCE, Kerendia, ULTOMIRIS, Ozempic, JYNARQUE.
Industry payments across CO — which companies pay providers there.
